AngioCure is currently seeking investment to take its revolutionary Clear Vessel technology to market. Investors who would like to gain access to our investor portal and review the AngioCure investor documents and due dillegence materials will first need to register with AngioCure and request access to the Investor Portal.
In an effort to protect AngioCure's Intellectual Property and to further adhere to the Securities and Exchange Commission's (SEC) Compliance Regulations under Rule 506(d) we would like to request that you complete the following steps prior to your access being granted.
Furthermore, all registrants need to be manually approved by the AngioCure team. Registration is not automated and will not provide you with instant access. The link to register is below the NDA. Thank you for your interest in AngioCure! We look forward to providing you with the information you require to make an informed investment decision.
Step 1: Read & Sign the Non-Disclosure Agreement (NDA)
Below is a link to the NDA for Investors which must be filled out and digitally authenticated/signed in order to finalize your registration. After you have completed and authenticated the NDA, you will go to the next step to request access to the AngioCure Investor Portal.
Step 2: Request Investor Access
After reading and submitting your digital authentication/signature for the NDA, you also need to register on the website for access to the investor portal. You will be presented with the page to request access after you complete the NDA.
It may take a short period of time for us to review your request before your access is granted. You will be notified by email when it has been approved.
PLEASE NOTE: The approval email will come from OneHub, not AngioCure. The email from OneHub links to the AngioCure Investor Portal data room. You will need to create a username and password on OneHub in order to gain access.
Thank you for your interest in AngioCure!